Haemoglobin Stanleyville II modifies sickle disease phenotype-Reference-Cited by-同舟云学术

Haemoglobin Stanleyville II modifies sickle disease phenotype

Published:2010-04 Issue:3 Volume:42 Page:310-312
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Burchall Genia,Maxwell Ellen

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference10 articles.

1. Haemoglobin Stanleyville II (α78 asparagine-> Lysine);Van Ros;Brit Med J,1968

2. Haemoglobin Stanleyville II (alpha75 [EF 7] Asn yeilds Lys) found in France;North;Acta Haematol,1975

3. Alpha-globin genes: thalassemic and structural alterations in a Brazilian population;Wenning;Braz J MedBiolRes,2000

4. Cytomorphologic signs of severe pernicious anemia obscured in a patient with heterozygous hemoglobin Stanleyville II;Draube;Eur J Haematol,2007

5. Australian Government Department of Immigration and Citizenship. Population Flows: Immigration Aspects 2006-07 edition. http://www.immi.gov.au/media/publications/statistics/popflows2006-7/ch1pt04.pdf (accessed 2 December 2008).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. X-ray crystallography and sickle cell disease drug discovery—a tribute to Donald Abraham;Frontiers in Molecular Biosciences;2023-05-24

2. Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease;Molecules;2022-10-12

3. Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property;Expert Opinion on Therapeutic Patents;2021-11-01

4. Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell Disease;Pharmaceutics;2021-07-27

5. VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions;Scientific Reports;2020-11-20